0001493152-21-004072.txt : 20210216
0001493152-21-004072.hdr.sgml : 20210216
20210216190439
ACCESSION NUMBER: 0001493152-21-004072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sakiris Spiro Kevin
CENTRAL INDEX KEY: 0001830957
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39825
FILM NUMBER: 21641847
MAIL ADDRESS:
STREET 1: 708 THIRD AVENUE, 6TH FLOOR
CITY: NEW YORK CITY
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GBS Inc.
CENTRAL INDEX KEY: 0001725430
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 821512711
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 733 THIRD AVENUE
STREET 2: FLOOR 15
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 646-790-5756
MAIL ADDRESS:
STREET 1: 733 THIRD AVENUE
STREET 2: FLOOR 15
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: Glucose Biosensor Systems (Greater China) Holdings, Inc.
DATE OF NAME CHANGE: 20171214
4
1
ownership.xml
X0306
4
2021-01-04
0
0001725430
GBS Inc.
GBS
0001830957
Sakiris Spiro Kevin
C/O GBS, INC., 708 THIRD AVENUE,
6TH FLOOR,
NEW YORK
NY
10017
0
1
0
0
Chief Financial Officer
Common Stock
2021-01-04
4
X
0
1479
A
6258
D
Series B Warrants
2021-01-04
4
X
0
1479
D
Common Stock
1479
0
D
Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date.
/s/ Spiro Sakiris
2021-02-16